A large international genetic study has identified 48 previously unrecognized regions of the human genome associated with Alzheimer's disease risk, providing researchers with a more detailed picture of the biological factors involved in the condition.

The research, published in Nature, combined data from 30 research groups and examined genetic information from approximately 2.8 million people, including 183,620 individuals diagnosed with Alzheimer's disease. Across this population, scientists identified 127 genomic regions associated with the likelihood of developing the condition.

The scale of the analysis makes the findings particularly significant: nearly half of the identified regions had not previously been linked to Alzheimer's risk in this context.

Brain immune cells emerge as an important research focus

Among the study's most notable findings is further evidence implicating microglia, the immune cells responsible for helping the brain remove harmful substances and damaged cellular material.

Researchers identified genetic signals associated with microglial activation and the recruitment of immune cells, strengthening the case for investigating how immune-related processes contribute to Alzheimer's disease.

The findings also point toward the involvement of particular types of neurons. For the first time, the researchers identified several specific neuronal populations enriched for genetic signals associated with the disease, offering additional directions for studying how Alzheimer's develops.

Another biological process highlighted by the analysis involves amyloid processing. Amyloid is a protein that can accumulate in the brain after Alzheimer's onset, and the genes identified in the study provide further clues about the mechanisms associated with its processing.

A broader picture of inherited risk

Emil Uffelmann of Vrije Universiteit Amsterdam, one of the study's authors, told Newsweek that the research identified 48 new genomic regions associated with Alzheimer's risk and highlighted the potential importance of microglia and specific neuronal populations.

He also noted that common genetic variants appear to contribute more substantially to Alzheimer's risk than previously estimated. This suggests that larger genetic studies may continue to uncover additional factors involved in the disease.

The research was led by the University of Oslo and Oslo University Hospital in Norway, working with an international research consortium.

From genetic discoveries to future treatment research

The findings could help scientists identify biological mechanisms that may eventually become targets for treatment development. By connecting genetic signals with particular brain cells and cellular processes, the study offers a more detailed framework for investigating the disease.

However, the researchers emphasized that improved genetic risk prediction remains a research tool rather than an established clinical application. The findings do not yet provide a basis for routine clinical prediction or treatment decisions.

The study's wider contribution lies in expanding the map of genetic factors associated with Alzheimer's and identifying new questions for future investigation. Understanding how these genetic signals interact with brain immune cells, neurons and amyloid-related processes may help guide the next stages of research into the disease..